866-945-0263 | enquiries@arrowheadpublishers.com

Press Releases

 August 1, 2013

Advances in Chronic Migraine Treatment

The 7th Annual Pain Therapeutics Summit East is the East Coast complement to the 7th Annual Pain Therapeutics Summit held on the West Coast. Year over year growth of this event necessitated an expansion into a bi-coastal pain summit. 

Chronic migraine (CM) and episodic migraine (EM) are part of the spectrum of migraine disorders, but they are distinct clinical entities. Episodic migraine (EM) is characterized by those with migraine who have 0 to 14 headache days per month, while chronic migraine (CM) is characterized by 15 or more headache days per month. As with episodic migraine, pain in chronic migraine patients is thought to be mediated through release of CGRP from terminals of trigeminal nerve neurons including those that innervate the dura. Dr. David C. Yeomans, Ph.D., Director of Pain Research, Faculty of Anesthesia, Stanford University School of Medicine and his team have shown that nasal application of oxytocin concentrates this peptide throughout the trigeminal nerve. At the 7th Annual Pain Therapeutic Summit, Dr. Yeomans will present, Cytokine-driven Analgesic Efficacy of Nasal Oxytocin in the Treatment of Chronic Migraine. The talk will highlight the team's findings and review future applications for Nasal oxytocin.

Nasal oxytocin is highly analgesic in a number of rat models of craniofacial pain, but only after induction of an inflammatory injury. In chronic migraineurs, who are chronically inflamed and should be chronically receptor upregulation, nasal oxytocin was highly effective in reducing their pain.  In addition, efficacy was found to be greatly reduced in those chronic migraineurs that had also taken an NSAID drug, which blocks the production of inflammatory cytokines, thus decreasing oxytocin receptor upregulation.

The 7th Annual Pain Therapeutics Summit East is the East Coast complement to the 7th Annual Pain Therapeutics Summit held on the West Coast. Year over year growth of this event necessitated an expansion into a bi-coastal pain summit. These events, while similar in theme have different agendas and speakers. Both promise to further the fields of pain research by bringing together leaders from a variety of pain related fields. For more information please visit www.paintherapeuticsummiteast.com or www.paintherapeuticsummit.com.

Source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258393/

 

Contact Us

PO Box 96
Chanhassen, MN 55317 USA
866-945-0263
www.arrowheadpublishers.com
enquiries@arrowheadpublishers.com

Speaker Opportunities

If you are interested in speaking at one of Arrowhead's conferences or would like to suggest a conference theme for which you have particular expertise, we'd like to hear from you.

Sponsor/Exhibitor Opportunities

Arrowhead sponsorship and exhibitor levels are designed to give your organization the highest level of exposure and opportunity to market products and branding in an environment that is targeted toward facilitating professional networking. We can also build tailor-made packages that will meet your organization's marketing budget and goals. Arrowhead sponsorships are proven to help grow businesses through direct and targeted exposure to industry leaders and decision makers. To gain critical industry exposure via our sponsorship and exhibiting opportunities, please contact us.